ArticleOncology letters2021

Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis.

Sung-Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.